Eisai Alzheimer's Disease Pipeline Research to be Presented at Virtual AD/PD™ 2021, Including Lecanemab (BAN2401) Data
Wednesday, March 10 Lecture Time: 12:45 - 13:00 Live Discussion: 17:00 - 17:30 Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE/ENGAGE, Phase 3 Studies of Aducanumab in Patients with Early Alzheimer's Disease Session: Aβ Targeting Therapies in AD 2 Saturday, March 13 Lecture Time: 12:45 - 13:00 Live Discussion: 17:30 - 18:00 Evaluation of Aducanumab Efficacy in Early Alzheimer's Disease. Session: Aβ Targeting Therapies in AD 2 Saturday, March 13 Lecture Time: 13:00 - 13:15 Live Discussion: 17:30 - 18:00 Evaluation of Aducanumab Safety in Early Alzheimer's Diseas...